Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents
Author:
Funder
European Association
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference72 articles.
1. Pathophysiology of liver fibrosis;Pinzani;Dig. Dis.,2015
2. Liver fibrosis: from the bench to clinical targets;Pinzani;Dig. Liver Dis.,2004
3. Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: a general population-based study;Fleming;J. Hepatol.,2008
4. The burden of liver disease in Europe: a review of available epidemiological data;Blachier;J. Hepatol.,2013
5. Hepatitis B virus infection — natural history and clinical consequences;Ganem;N. Engl. J. Med.,2004
Cited by 105 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy;ACS Nano;2024-01-30
2. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents;Journal of Materials Chemistry B;2024
3. Hepatic Encephalopathy as a Gliopathy;Physiology and Function of Glial Cells in Health and Disease;2023-12-18
4. Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis;Frontiers in Pharmacology;2023-12-12
5. Total flavonoids extracted from Penthorum chinense Pursh mitigates CCl4-induced hepatic fibrosis in rats via inactivation of TLR4-MyD88-mediated NF-κB pathways and regulation of liver metabolism;Frontiers in Pharmacology;2023-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3